Clinical Trial Update: Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Phase 3]

View source ↗

Summary

Phase 3 comparative efficacy and safety trial in Ulcerative Colitis in remission has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Tillotts Pharma AG | Conditions: Ulcerative Colitis in Remission | Phase 3 | Status: COMPLETED